Concepts (87)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Defects, Congenital | 6 | 2024 | 1782 | 0.690 |
Why?
|
| Hypothermia, Induced | 1 | 2019 | 177 | 0.590 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2017 | 394 | 0.510 |
Why?
|
| Heart Arrest | 1 | 2019 | 373 | 0.480 |
Why?
|
| Weight Gain | 1 | 2017 | 475 | 0.470 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2016 | 143 | 0.470 |
Why?
|
| Monitoring, Physiologic | 2 | 2016 | 536 | 0.460 |
Why?
|
| Coronary Care Units | 1 | 2013 | 51 | 0.450 |
Why?
|
| Critical Care | 3 | 2016 | 808 | 0.400 |
Why?
|
| Down Syndrome | 1 | 2013 | 227 | 0.370 |
Why?
|
| Hemodynamics | 1 | 2013 | 971 | 0.330 |
Why?
|
| Pain, Postoperative | 1 | 2013 | 654 | 0.300 |
Why?
|
| Heart Diseases | 1 | 2013 | 738 | 0.290 |
Why?
|
| Obesity | 1 | 2017 | 2940 | 0.250 |
Why?
|
| Spectroscopy, Near-Infrared | 2 | 2016 | 172 | 0.230 |
Why?
|
| Analgesics, Opioid | 1 | 2013 | 1457 | 0.220 |
Why?
|
| Oximetry | 2 | 2016 | 187 | 0.220 |
Why?
|
| Teaching Rounds | 1 | 2022 | 36 | 0.210 |
Why?
|
| Postoperative Complications | 1 | 2017 | 5685 | 0.200 |
Why?
|
| Heart Failure | 1 | 2016 | 2496 | 0.200 |
Why?
|
| Pulmonary Artery | 1 | 2024 | 520 | 0.180 |
Why?
|
| Asphyxia | 1 | 2019 | 20 | 0.170 |
Why?
|
| Heart Ventricles | 1 | 2024 | 846 | 0.160 |
Why?
|
| Health Information Systems | 1 | 2019 | 37 | 0.160 |
Why?
|
| Risk Adjustment | 1 | 2017 | 77 | 0.150 |
Why?
|
| Linear Models | 2 | 2017 | 1093 | 0.150 |
Why?
|
| Palivizumab | 1 | 2017 | 65 | 0.140 |
Why?
|
| Chlorothiazide | 1 | 2016 | 13 | 0.140 |
Why?
|
| Child Development | 1 | 2019 | 268 | 0.140 |
Why?
|
| Nephrons | 1 | 2016 | 47 | 0.140 |
Why?
|
| Diuresis | 1 | 2016 | 64 | 0.140 |
Why?
|
| Equipment and Supplies, Hospital | 1 | 2015 | 15 | 0.130 |
Why?
|
| Alprostadil | 1 | 2015 | 37 | 0.130 |
Why?
|
| Cardiac Output | 1 | 2016 | 197 | 0.130 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2017 | 261 | 0.120 |
Why?
|
| Developmental Disabilities | 1 | 2019 | 689 | 0.120 |
Why?
|
| Vasodilator Agents | 1 | 2015 | 238 | 0.120 |
Why?
|
| Catheterization, Swan-Ganz | 1 | 2013 | 18 | 0.110 |
Why?
|
| Infant | 5 | 2024 | 13891 | 0.110 |
Why?
|
| Referral and Consultation | 1 | 2019 | 934 | 0.110 |
Why?
|
| Infant, Newborn | 4 | 2024 | 8578 | 0.110 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2017 | 435 | 0.110 |
Why?
|
| Heart | 1 | 2019 | 1211 | 0.100 |
Why?
|
| Pregnancy Complications | 1 | 2017 | 556 | 0.100 |
Why?
|
| Consensus | 1 | 2017 | 1103 | 0.100 |
Why?
|
| Critical Illness | 1 | 2016 | 742 | 0.090 |
Why?
|
| Infant, Premature | 1 | 2016 | 825 | 0.090 |
Why?
|
| Body Mass Index | 1 | 2017 | 2237 | 0.090 |
Why?
|
| Humans | 12 | 2024 | 270856 | 0.080 |
Why?
|
| Length of Stay | 1 | 2015 | 2012 | 0.080 |
Why?
|
| Risk Assessment | 1 | 2019 | 6832 | 0.070 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 4983 | 0.060 |
Why?
|
| Pregnancy | 1 | 2017 | 8042 | 0.060 |
Why?
|
| Retrospective Studies | 4 | 2024 | 39688 | 0.060 |
Why?
|
| Male | 7 | 2024 | 128412 | 0.060 |
Why?
|
| Ductus Arteriosus | 1 | 2024 | 65 | 0.060 |
Why?
|
| Female | 7 | 2024 | 148467 | 0.050 |
Why?
|
| Brain | 1 | 2016 | 4256 | 0.050 |
Why?
|
| Professional-Family Relations | 1 | 2022 | 130 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2024 | 33819 | 0.050 |
Why?
|
| Child, Preschool | 3 | 2024 | 16957 | 0.040 |
Why?
|
| Child | 2 | 2022 | 30380 | 0.040 |
Why?
|
| Young Adult | 1 | 2017 | 22054 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2017 | 5105 | 0.040 |
Why?
|
| Family | 1 | 2022 | 762 | 0.040 |
Why?
|
| Abnormalities, Multiple | 1 | 2024 | 1013 | 0.040 |
Why?
|
| Intensive Care Units | 1 | 2022 | 741 | 0.040 |
Why?
|
| Hospitals, Pediatric | 1 | 2022 | 789 | 0.040 |
Why?
|
| Patient Care Team | 1 | 2022 | 826 | 0.040 |
Why?
|
| Furosemide | 1 | 2016 | 42 | 0.040 |
Why?
|
| Texas | 2 | 2019 | 6413 | 0.030 |
Why?
|
| Respiratory Syncytial Viruses | 1 | 2017 | 175 | 0.030 |
Why?
|
| Birthing Centers | 1 | 2015 | 10 | 0.030 |
Why?
|
| Injections, Intravenous | 1 | 2016 | 596 | 0.030 |
Why?
|
| Diuretics | 1 | 2016 | 180 | 0.030 |
Why?
|
| Prognosis | 1 | 2013 | 22456 | 0.030 |
Why?
|
| Immunization | 1 | 2017 | 403 | 0.030 |
Why?
|
| DNA, Viral | 1 | 2017 | 763 | 0.030 |
Why?
|
| Morbidity | 1 | 2015 | 403 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 15247 | 0.030 |
Why?
|
| Adult | 1 | 2017 | 81545 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2016 | 2366 | 0.020 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2019 | 1162 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2017 | 1255 | 0.020 |
Why?
|
| Incidence | 1 | 2019 | 5840 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 4331 | 0.020 |
Why?
|
| Risk Factors | 1 | 2019 | 17820 | 0.010 |
Why?
|